![Early chemotherapy improves survival for men with prostate cancer | UCL News - UCL – University College London Early chemotherapy improves survival for men with prostate cancer | UCL News - UCL – University College London](https://www.ucl.ac.uk/news/sites/news/files/docetaxel.jpg)
Early chemotherapy improves survival for men with prostate cancer | UCL News - UCL – University College London
![Network Pharmacology-Based identification of pharmacological mechanism of SQFZ injection in combination with Docetaxel on lung cancer | Scientific Reports Network Pharmacology-Based identification of pharmacological mechanism of SQFZ injection in combination with Docetaxel on lung cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-40954-3/MediaObjects/41598_2019_40954_Fig1_HTML.png)
Network Pharmacology-Based identification of pharmacological mechanism of SQFZ injection in combination with Docetaxel on lung cancer | Scientific Reports
![Frontiers | Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report Frontiers | Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report](https://www.frontiersin.org/files/Articles/809527/fonc-11-809527-HTML/image_m/fonc-11-809527-g001.jpg)
Frontiers | Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report
![Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial - The Lancet Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/10efaecc-6fad-4e0b-abd7-2a6467115a9a/gr1_lrg.gif)
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial - The Lancet
![C42Band LNCaP Docetaxel drug response. C42B and LNCaP cells in 2D and... | Download Scientific Diagram C42Band LNCaP Docetaxel drug response. C42B and LNCaP cells in 2D and... | Download Scientific Diagram](https://www.researchgate.net/publication/322367531/figure/fig5/AS:581297975369728@1515603645959/C42Band-LNCaP-Docetaxel-drug-response-C42B-and-LNCaP-cells-in-2D-and-3D-cultures-were.png)
C42Band LNCaP Docetaxel drug response. C42B and LNCaP cells in 2D and... | Download Scientific Diagram
![Processes | Free Full-Text | Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review Processes | Free Full-Text | Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review](https://www.mdpi.com/processes/processes-09-01086/article_deploy/html/images/processes-09-01086-g003.png)
Processes | Free Full-Text | Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review
![Processes | Free Full-Text | Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review Processes | Free Full-Text | Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review](https://pub.mdpi-res.com/processes/processes-09-01086/article_deploy/html/images/processes-09-01086-g001.png?1624434463)
Processes | Free Full-Text | Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review
![Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer | Journal of Urology Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer | Journal of Urology](https://www.auajournals.org/cms/asset/6c88e145-f5f0-4e04-9616-a9612536b144/abs-fig.jpg)